RWD Study in HER2+ mBC Patients in Third-Line Therapy

Clinical trial NCT04566458 · COMPLETED

Trial details

NCT number: NCT04566458
Sponsor: Exactis Innovation
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Stage IV

Start date: 2020-10-01
Primary completion: 2021-05-30
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.